logo
Nornickel's first-half net profit up 2% to $842 million

Nornickel's first-half net profit up 2% to $842 million

Reutersa day ago
MOSCOW, Aug 4 (Reuters) - Russian metals producer Nornickel (GMKN.MM), opens new tab said on Monday its net profit for the first six months of 2025 rose 2% to $842 million, helped by a reduction in accumulated inventories.
Revenues at Nornickel, a major producer of refined nickel and palladium, increased 15% to $6.46 billion, while earnings before interest, tax, depreciation and amortisation rose 12% to $2.63 billion, it said.
"The company's financial performance improved somewhat, despite mixed performance of commodity prices and unfavourable forex movements," CEO Vladimir Potanin said in a statement.
"As our logistics were further adjusted, management was able to reduce accumulated inventories, while keeping the increase in cash operating costs below the inflation rate," Potanin added.
Nornickel's shares were up 1.1% on the Moscow Stock Exchange.
Potanin noted the company raised $2.4 billion using instruments denominated in U.S. dollars and China's yuan and increased investment by 15% to $1.1 billion.
He added that the company was developing digital and artificial intelligence tools, estimating their contribution to the company's annual EBITDA at $100 million.
While Nornickel is not subject to direct Western sanctions over Russia's actions in Ukraine, the measures have prompted some producers to avoid buying Russian metal, complicated payments, and restricted access to Western equipment.
Nornickel's net profit fell 37% in 2024 as Western sanctions and low metals prices squeezed earnings.
The company said that improved logistics in the first half of the year enabled it to sell off stocks of metals. It added that the start of interest rate cutting by Russia's central bank would lower debt servicing costs.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump envoy to land in Moscow as US 'peace or sanctions' deadline looms over Putin
Trump envoy to land in Moscow as US 'peace or sanctions' deadline looms over Putin

Daily Mail​

timean hour ago

  • Daily Mail​

Trump envoy to land in Moscow as US 'peace or sanctions' deadline looms over Putin

US President Donald Trump 's peace envoy is expected to travel to Moscow imminently ahead of Friday's deadline for Russia to agree a ceasefire with Ukraine. Steve Witkoff is likely to hold urgent discussions with senior Kremlin officials as soon as Wednesday in a bid to bring Russia to the negotiating table. Russia could face economic sanctions from Friday, affecting itself and trading partners such as China and India, unless Vladimir Putin agrees to talks. President Trump initially gave President Putin 50 days to strike a peace deal then cut the time to '10 to 12 days'. Ahead of the deadline, Russia has pulled out of a nuclear missile agreement intended to limit numbers of short to medium range missiles in Europe. Witkoff has been criticised for the tone of his previous visits to Russia. At times he has appeared fawning in Putin's presence and has failed to secure any concessions. After one meeting earlier this year, Putin presented Witkoff with a portrait of President Trump to take back to the White House. This afternoon, Ukraine's President Volodymyr Zelensky confirmed on social media he has spoken President Trump. But he did not mention the deadline. Ukrainian President Volodymyr Zelensky confirmed today he and US President Donald Trump enjoyed a 'productive' conversation on Tuesday about ending the three-year conflict. President Zelensky described their conversation as 'productive' with the 'key focus of course being ending the war'. He added Ukraine and the United States have 'coordinated our positions' while the Russians have 'intensified the brutality of their attacks'. President Trump's plan is to hit Russia with 'secondary tariffs' in a bid to end the war. These will punish states that purchase Russian energy supplies, making it more expensive for these countries to sell goods into the United States. As a major importer of Russian oil, India is particularly vulnerable. Its government has protested the unfairness of the strategy, claiming India's critics also import Russian goods. Trump has accused of India of 'fuelling [Russia's] war machine'. India has called the 100 per cent secondary tariffs 'unjustified and unreasonable'. Ukraine claimed earlier this week that it has found Indian-made components inside Russian attack drones fired at its cities. Indian Prime Minister Narendra Modi is also said to be personally close to Putin. They appear to share a warm relationship and are economic allies. Putin is widely expected to ignore Trump's deadline. While the US President has repeatedly excused Putin's failure to agree peace terms. But with President Trump under pressure in the US over his connections to sex trafficker Jeffrey Epstein, he may adopt a tougher stance towards Putin. President Trump signalled his intent last week by publicly stating he had repositioned a pair of US nuclear submarines closer to Russia to keep the Kremlin in check. Russia responded strongly declaring it was pulling out of a nuclear missile agreement due to 'destabilising actions' by Western powers. So far, the Kremlin's only step towards peace has been a pledge by Putin's spokesperson Dmitry Peskov that the Russian President will meet President Zelensky. But the offer was subject to caveats around Russia's demands for a negotiated end to the conflict. Witkoff is expected to outline economic sanctions the US is likely to impose on Russia. Peskov has said the Kremlin considers its contacts with US Special Envoy Witkoff 'important and useful'.

Morrisons cuts another 3,600 jobs
Morrisons cuts another 3,600 jobs

Daily Mail​

timean hour ago

  • Daily Mail​

Morrisons cuts another 3,600 jobs

Morrisons slashed more than 3,600 jobs last year as the embattled retailer turned a profit for the first time since its 2021 private equity takeover. The group, which cut more than 8,800 jobs in 2023, saw its headcount fall from 104,819 to 101,144 in the 12 months to 27 October 2024, Companies House accounts published this week show. Cost cutting efforts helped Morrisons swing to a pre-tax profit of £2.1billion for 2024, having suffered losses of £919million and £1.3billion in the previous two years respectively. However, it saw group revenues slump from £18.3billion to £17billion for the year. Morrisons' market share has increasingly come under pressure from European discounters, with Lidl poised to take its spot as Britain's fifth largest supermarket after double-digit growth in the second quarter. The group has already lost its position as the fourth-biggest grocer in Britain to Aldi. Job losses in the year to the end of October 2024 were compounded in March when Morrisons announced it cut more than 350 jobs across its cafes, convenience stores, florists and fresh food counters following the introduction of higher labour costs in last year's Autumn Budget . Morrisons is now alone among the supermarket sector in pushing ahead with staff cuts, with Aldi, Tesco and Sainsbury's all announcing job losses since the Autumn Budget.

Hims & Hers falls as weight loss treatment shift hurts revenues
Hims & Hers falls as weight loss treatment shift hurts revenues

Reuters

timean hour ago

  • Reuters

Hims & Hers falls as weight loss treatment shift hurts revenues

Aug 5 (Reuters) - Shares of Hims & Hers (HIMS.N), opens new tab fell nearly 9% on Tuesday after the telehealth firm reported weaker-than-expected quarterly revenue, in part as its move from branded to lower-cost, personalized weight loss treatments led to lower revenue per subscriber. Hims said it saw strong demand for its weight-loss offerings in the second quarter, but noted that a pivot toward personalized compounded GLP-1 treatments lowered the revenue it earned per order versus its previous compounded offering. The new personalized offering is more costly to run, the company said. Compounded medications are less expensive than branded drugs like Novo Nordisk's ( opens new tab Wegovy, which Hims had offered under a now-terminated partnership with the Danish drugmaker. Hims reported $190 million in GLP-1-related revenue during the quarter, down around $40 million from the preceding quarter. Overall platform subscriptions rose 31% year-over-year. Leerink Partners analysts flagged the GLP-1 revenue dip as expected. However, the market reaction was negative after the results, as investor expectations were elevated due to a surge in Hims' shares this year. The company's stock has more than doubled so far this year, while Denmark-listed shares of Novo have fallen over 50%. The brokerage called the softness in Hims' core business, which includes treatments for conditions related to sexual health, a negative surprise. Hims & Hers reported a decline in its subscribers for its sexual health business, which sells generic drugs for erectile dysfunction, in the second quarter. Canaccord Genuity echoed a near-term caution for the company, but remained constructive on the longer-term growth potential, citing strong year-over-year gains in newer specialties such as dermatology, weight management, and daily-use sexual health solutions. Despite the stock's sharp post-earnings pullback, the brokerage called the move a potential buying opportunity. Hims shares are priced at 95.85 times the company's estimated earnings for the next 12 months, a common benchmark for valuing stocks.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store